DCF — PROVIDENCE PORTLAND MEDICAL CENTER
Enterprise Value: $-820.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-820.6M
Enterprise Value
$-274.5M
PV of Cash Flows
$-546.1M
PV of Terminal Value
$-879.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $955.6M | $-43.0M | -4.0% | $-83.5M | $-75.9M |
| Year 2 | $984.3M | $-34.5M | -3.0% | $-76.1M | $-62.9M |
| Year 3 | $1.0B | $-25.3M | -2.0% | $-68.3M | $-51.3M |
| Year 4 | $1.0B | $-20.9M | -2.0% | $-65.1M | $-44.5M |
| Year 5 | $1.1B | $-18.8M | -2.0% | $-64.4M | $-40.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-820.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$927.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999989221814
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5